Trusopt and Eyelid disorder - a phase IV clinical study of FDA data

Summary:

Eyelid disorder is reported as a side effect among people who take Trusopt (dorzolamide hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xalatan, and have Eye allergy.

The phase IV clinical study analyzes which people have Eyelid disorder when taking Trusopt. It is created by eHealthMe based on reports of 3,123 people who have side effects when taking Trusopt from the FDA, and is updated regularly.

What is Trusopt?

Trusopt has active ingredients of dorzolamide hydrochloride. It is often used in glaucoma. eHealthMe is studying from 3,165 Trusopt users. Check the latest studies of Trusopt.

What is Eyelid disorder?

Eyelid disorder is found to be associated with 336 drugs and 456 conditions by eHealthMe. Check the latest studies of Eyelid disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

3,123 people reported to have side effects when taking Trusopt.
Among them, 22 people (0.7%) have Eyelid disorder.

Among these 22 people:

How long have people been on Trusopt when they have Eyelid disorder? *

What is the gender of people who have Eyelid disorder when taking Trusopt? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Eyelid disorder when taking Trusopt? *

What are other drugs people take besides Trusopt? *

Xalatan: 10 people, 45.45%
Amlodipine: 7 people, 31.82%
Timoptic: 5 people, 22.73%
Cozaar: 5 people, 22.73%
Latanoprost: 3 people, 13.64%
Azopt: 3 people, 13.64%
Fluorometholone: 2 people, 9.09%
Alphagan: 2 people, 9.09%
Losartan Potassium And Hydrochlorothiazide: 2 people, 9.09%
Lumigan: 2 people, 9.09%

What are other side effects people have besides Eyelid disorder? *

Growth Of Eyelashes: 9 people, 40.91%
Intraocular Pressure Increased: 7 people, 31.82%
Body Height Decreased: 7 people, 31.82%
Cataract (clouding of the lens inside the eye): 7 people, 31.82%
Chest Pain: 7 people, 31.82%
Confusional State: 7 people, 31.82%
Dizziness: 7 people, 31.82%
Dysgraphia (impaired ability to learn to write): 7 people, 31.82%
Dyspnea (difficult or laboured breathing): 7 people, 31.82%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 7 people, 31.82%

What are the existing conditions these people have? *

Intraocular Pressure Increased: 1 person, 4.55%
Eye Allergy: 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Trusopt and have Eyelid disorder?

- Check whether Eyelid disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Trusopt:

Trusopt (3,165 reports)

Eyelid disorder treatments and more:

Eyelid disorder (2,758 reports)

Browse all side effects of Trusopt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eyelid disorder:

Eyelid disorder (336 drugs)

Browse all the conditions that are associated with Eyelid disorder:

Eyelid disorder (456 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dorzolamide hydrochloride (the active ingredients of Trusopt) and Trusopt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.